4//SEC Filing
Mano Michael 4
Accession 0001209191-23-014865
CIK 0001503802other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:35 PM ET
Size
6.8 KB
Accession
0001209191-23-014865
Insider Transaction Report
Form 4
Mano Michael
SVP, General Counsel&Secretary
Transactions
- Award
Common Stock
2023-02-28+70,000→ 153,000 total - Sale
Common Stock
2023-03-01$3.03/sh−6,878$20,835→ 146,122 total
Footnotes (2)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2024.
- [F2]This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001837741
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 5:35 PM ET
- Size
- 6.8 KB